Share Twitter LinkedIn Facebook Email David Siegel, MD, Hematologist/Oncologist, Hackensack University Medical Center, John Theurer Cancer Center, discusses Thoughts On The Daratumamab Studies. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Cell Therapy for Solid Tumors: Immunotherapy Biomarkers Anusha Kalbasi, MD MOASC [2023] Immunotherapy 2 Mins Read